Role of NFkappaB in the mortality of sepsis.
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Binding activity for nuclear factor kappa B (NFkappaB) consensus probes was studied in nuclear extracts from peripheral blood mononuclear cells of 15 septic patients (10 surviving and 5 not surviving). Nonsurvivors could be distinguished from survivors by an increase in NFkappaB binding activity during the observation period (P < 0.001). The increase in NFkappaB binding activity was comparable to the APACHE-II score as a predictor of outcome. Intravenous somatic gene transfer with an expression plasmid coding for IkappaBalpha was used to investigate the role of members of the NFkappaB family in a mouse model of endotoxemia. In this model, increased NFkappaB binding activity was present after injection of LPS. Intravenous somatic gene transfer with IkappaBalpha given before LPS attenuated renal NFkappaB binding activity and increased survival. Endothelial cells and monocytes/macrophages were the major target cells for somatic gene transfer, transfected with an average transfection efficiency of 20-35%. Tissue factor, a gene under regulatory control of NFkappaB, was induced by LPS. Somatic gene transfer with a reporter plasmid containing the functional tissue factor promoter demonstrated NFkappaB-dependent stimulation by LPS. Intravenous somatic gene transfer with IkappaBalpha reduced LPS-induced renal tissue factor expression, activation of the plasmatic coagulation system (decrease of thrombin-antithrombin III complexes) and renal fibrin/fibrinogen deposition. Somatic gene transfer with an expression plasmid with tissue factor cDNA in the antisense direction (in contrast to sense or vector alone) also increased survival. Furthermore, antisense tissue factor decreased renal tissue factor expression and the activation of the plasmatic coagulation system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Firefly luciferase gene: structure and expression in mammalian cells.
de Wet, J. R., Wood, K. V., DeLuca, M., Helinski, D. R., & Subramani, S. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.725 · Cited by 3,087
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
Nawroth, P. P., & Stern, D. M. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.3.740 · Cited by 1,311
Self-citationBevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,067
Galactosamine-induced sensitization to the lethal effects of endotoxin.
Galanos, C., Freudenberg, M. A., & Reutter, W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5939 · Cited by 929
DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide
Nolan, G. P., Ghosh, S., Liou, H.-C., Tempst, P., & Baltimore, D. (1991) · Cell · doi:10.1016/0092-8674(91)90320-x · Cited by 596
Cited by
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Bouchama, A., & Knochel, J. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011089 · Cited by 1,898
Inflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
Molecular inflammation: Underpinnings of aging and age-related diseases
Chung, H. Y., Cesari, M., Anton, S., Marzetti, E., Giovannini, S., Seo, A. Y., Carter, C., Yu, B. P., & Leeuwenburgh, C. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.002 · Cited by 1,203
“1, NF-κB is also known to regulate the transcription of pro-inflammatory molecules, such as TNF-α and TNF-β, interleukins (IL-1β, IL-2, and IL-6), chemokines (IL-8 and RANTES), AMs, including ICAM-1, VCAM, E-selectin, and enzymes, including iNOS and COX-2 (Brand et al., 1996; Bohrer et al., 1997).”
BackgroundThe role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Corticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Hydrocortisone Infusion for Severe Community-acquired Pneumonia: A Preliminary Randomized Study
Confalonieri, M., Urbino, R., Potena, A., Piattella, M., Parigi, P., Puccio, G., Della Porta, R., Giorgio, C., Blasi, F., Umberger, R., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-808oc · Cited by 857
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
Self-citationNF-κB activation as a pathological mechanism of septic shock and inflammation
Liu, S. F., & Malik, A. B. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00477.2005 · Cited by 761
Inflammatory cytokines and cell response in surgery
Lin, E., Calvano, S. E., & Lowry, S. F. (2000) · Surgery · doi:10.1067/msy.2000.101584 · Cited by 574
Infection and inflammation and the coagulation system
Levi, M. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00857-x · Cited by 517
Oxidative stress and gene expression in sepsis
Macdonald, J., Galley, H. F., & Webster, N. R. (2003) · British Journal of Anaesthesia · doi:10.1093/bja/aeg034 · Cited by 497
Chen, L.-W., Egan, L., Li, Z.-W., Greten, F. R., Kagnoff, M. F., & Karin, M. (2003) · Nature Medicine · doi:10.1038/nm849 · Cited by 483
Transcription factor-κB (NF-κB) and renal disease
Guijarro, C., & Egido, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002415.x · Cited by 479
Stress-hyperglycemia, insulin and immunomodulation in sepsis
Marik, P. E., & Raghavan, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2167-y · Cited by 419
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Free radicals and lipid peroxidation mediated injury in burn trauma: the role of antioxidant therapy
Horton, J. W. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00154-9 · Cited by 361
Liu, S. F., Ye, X., & Malik, A. B. (1999) · Circulation · doi:10.1161/01.cir.100.12.1330 · Cited by 346
The Role of Nuclear Factor-κ B in Pulmonary Diseases
Christman, J. W., Sadikot, R. T., & Blackwell, T. S. (2000) · Chest · doi:10.1378/chest.117.5.1482 · Cited by 318
Immune cells: free radicals and antioxidants in sepsis
Victor, V. M., Rocha, M., & De la Fuente, M. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.020 · Cited by 310
Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences
Rauch, U., Osende, J. I., Fuster, V., Badimon, J. J., Fayad, Z., & Chesebro, J. H. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00014 · Cited by 297
Molecular inflammation hypothesis of aging based on the anti‐aging mechanism of calorie restriction
Chung, H. Y., Kim, H. J., Kim, K. W., Choi, J. S., & Yu, B. P. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10203 · Cited by 297
Camenisch, T. D., Koller, B. H., Earp, H. S., & Matsushima, G. K. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3498 · Cited by 290
Statins and sepsis: multiple modifications at multiple levels
Terblanche, M., Almog, Y., Rosenson, R. S., Smith, T. S., & Hackam, D. G. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70111-1 · Cited by 271
Weigert, C., Brodbeck, K., Staiger, H., Kausch, C., Machicao, F., Häring, H. U., & Schleicher, E. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312692200 · Cited by 269
Meduri, G. U., Tolley, E. A., Chrousos, G. P., & Stentz, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2106014 · Cited by 265
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01315.x · Cited by 263
Activation and Regulation of Systemic Inflammation in ARDS
Meduri, G. U., Annane, D., Chrousos, G. P., Marik, P. E., & Sinclair, S. E. (2009) · Chest · doi:10.1378/chest.08-2408 · Cited by 260
Zhang, W.-J., Wei, H., Hagen, T., & Frei, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700305104 · Cited by 257
Abraham, E. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004001-00012 · Cited by 256
Predictive Value of Nuclear Factor κB Activity and Plasma Cytokine Levels in Patients with Sepsis
Arnalich, F., Garcia-Palomero, E., López, J., Jiménez, M., Madero, R., Renart, J., Vázquez, J. J., & Montiel, C. (2000) · Infection and Immunity · doi:10.1128/iai.68.4.1942-1945.2000 · Cited by 252
Nuclear Factor–κB and Its Role in Sepsis‐Associated Organ Failure
Abraham, E. (2003) · The Journal of Infectious Diseases · doi:10.1086/374750 · Cited by 234
Transcription factor NF-κB as a potential biomarker for oxidative stress
van den Berg, R., Haenen, G. R. M. M., van den Berg, H., & Bast, A. (2001) · British Journal of Nutrition · doi:10.1079/bjn2001340 · Cited by 202
Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-κB Transactivation at the IL-1β Promoter
Chan, C., Li, L., McCall, C. E., & Yoza, B. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.461 · Cited by 180
Schiekofer, S., Andrassy, M., Chen, J., Rudofsky, G., Schneider, J., Wendt, T., Stefan, N., Humpert, P., Fritsche, A., Stumvoll, M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.3.621 · Cited by 180
Self-citationNuclear factor-κB as a therapeutic target in critical care medicine
Zingarelli, B., Sheehan, M., & Wong, H. R. (2003) · Critical Care Medicine · doi:10.1097/00003246-200301001-00015 · Cited by 174
Meduri, G. U., Muthiah, M. P., Carratù, P., Eltorky, M., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000091126 · Cited by 167
The Interaction Between Pathogens and the Host Coagulation System
Sun, H. (2006) · Physiology · doi:10.1152/physiol.00059.2005 · Cited by 162
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157
“In acute inflammatory conditions such as sepsis, genetic polymorphisms potentiating NF-κB activation have been found to increase mortality because of excessive inflammation [41,42].”
BackgroundA potential role of activated NF-κB in the pathogenesis of euthyroid sick syndrome
Nagaya, T., Fujieda, M., Otsuka, G., Yang, J.-P., Okamoto, T., & Seo, H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7771 · Cited by 107
A critical assessment of some biomarker approaches linked with dietary intake
Crews, H., Alink, G., Andersen, R., Braesco, V., Holst, B., Maiani, G., Ovesen, L., Scotter, M., Solfrizzo, M., van den Berg, R., et al. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001337 · Cited by 99
“Increased activation has already been shown in patients with leprosy (Zea et al. 1998), sepsis (Bo¨hrer et al. 1997) and with type-1 diabetes (Hofmann et al. 1998).”
Serum amyloid A1 mediates myotube atrophy via Toll‐like receptors
Hahn, A., Kny, M., Pablo‐Tortola, C., Todiras, M., Willenbrock, M., Schmidt, S., Schmoeckel, K., Jorde, I., Nowak, M., Jarosch, E., et al. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12491 · Cited by 67
STAT4 and STAT6 regulate systemic inflammation and protect against lethal endotoxemia
Lentsch, A. B., Kato, A., Davis, B., Wang, W., Chao, C., & Edwards, M. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113763 · Cited by 63
Apocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state
Trevelin, S. C., dos Santos, C. X., Ferreira, R. G., de Sá Lima, L., Silva, R. L., Scavone, C., Curi, R., Alves-Filho, J. C., Cunha, T. M., Roxo-Júnior, P., et al. (2016) · Scientific Reports · doi:10.1038/srep34581 · Cited by 48
Metadata
- Authors
- Böhrer, H., Qiu, F., Zimmermann, T., Zhang, Y., Jllmer, T., Männel, D., Böttiger, B. W., Stern, D. M., Waldherr, R., Saeger, H. D., Ziegler, R., Bierhaus, A., Martin, E., & Nawroth, P. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-09-01
- Volume
- 100
- Issue
- 5
- Pages
- 972-985
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1992456193
- Cited by
- 454
- References
- 54
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.